nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.341	1	CpDpCtD
Glucosamine—MMP9—chronic obstructive pulmonary disease	0.25	0.604	CbGaD
Glucosamine—TNF—chronic obstructive pulmonary disease	0.164	0.397	CbGaD
Glucosamine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0446	0.359	CbGbCtD
Glucosamine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0329	0.265	CbGbCtD
Glucosamine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0329	0.265	CbGbCtD
Glucosamine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0138	0.111	CbGbCtD
Glucosamine—NFKB2—bronchus—chronic obstructive pulmonary disease	0.00297	0.139	CbGeAlD
Glucosamine—NFKB2—trachea—chronic obstructive pulmonary disease	0.00267	0.125	CbGeAlD
Glucosamine—IFNG—respiratory system—chronic obstructive pulmonary disease	0.00245	0.115	CbGeAlD
Glucosamine—IFNG—connective tissue—chronic obstructive pulmonary disease	0.00216	0.101	CbGeAlD
Glucosamine—IFNG—bronchus—chronic obstructive pulmonary disease	0.00201	0.0945	CbGeAlD
Glucosamine—NFKB2—lung—chronic obstructive pulmonary disease	0.00192	0.0899	CbGeAlD
Glucosamine—MMP9—respiratory system—chronic obstructive pulmonary disease	0.00157	0.0737	CbGeAlD
Glucosamine—MMP9—connective tissue—chronic obstructive pulmonary disease	0.00138	0.0649	CbGeAlD
Glucosamine—IFNG—lung—chronic obstructive pulmonary disease	0.0013	0.061	CbGeAlD
Glucosamine—MMP9—smooth muscle tissue—chronic obstructive pulmonary disease	0.00127	0.0593	CbGeAlD
Glucosamine—Streptozocin—CYP1A1—chronic obstructive pulmonary disease	0.000867	0.509	CrCbGaD
Glucosamine—Streptozocin—CYP1A2—chronic obstructive pulmonary disease	0.000836	0.491	CrCbGaD
Glucosamine—MMP9—lung—chronic obstructive pulmonary disease	0.000835	0.0391	CbGeAlD
Glucosamine—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000518	0.0243	CbGeAlD
Glucosamine—NFKB2—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000469	0.253	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000469	0.253	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000458	0.247	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000458	0.247	CbGdCrCtD
Glucosamine—CYP2E1—lung—chronic obstructive pulmonary disease	0.000275	0.0129	CbGeAlD
Glucosamine—NFKB2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	7.28e-05	0.000763	CbGpPWpGaD
Glucosamine—IFNG—Immune System—RAPGEF3—chronic obstructive pulmonary disease	7.21e-05	0.000756	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	7.19e-05	0.000754	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	7.18e-05	0.000752	CbGpPWpGaD
Glucosamine—NFKB2—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	7.15e-05	0.000749	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.15e-05	0.000749	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL6—chronic obstructive pulmonary disease	7.13e-05	0.000747	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.12e-05	0.000747	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	7.11e-05	0.000746	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	7.1e-05	0.000744	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—ALB—chronic obstructive pulmonary disease	7.1e-05	0.000744	CbGpPWpGaD
Glucosamine—IFNG—Immune System—LY96—chronic obstructive pulmonary disease	7.01e-05	0.000735	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	6.99e-05	0.000733	CbGpPWpGaD
Glucosamine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.96e-05	0.00073	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	6.95e-05	0.000729	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL6—chronic obstructive pulmonary disease	6.91e-05	0.000725	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	6.9e-05	0.000723	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	6.9e-05	0.000723	CbGpPWpGaD
Glucosamine—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	6.87e-05	0.000721	CbGpPWpGaD
Glucosamine—NFKB2—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	6.78e-05	0.000711	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TLR2—chronic obstructive pulmonary disease	6.74e-05	0.000707	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	6.69e-05	0.000702	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TGFB1—chronic obstructive pulmonary disease	6.67e-05	0.0007	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—chronic obstructive pulmonary disease	6.58e-05	0.00069	CbGpPWpGaD
Glucosamine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.56e-05	0.000688	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.54e-05	0.000685	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.53e-05	0.000684	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—IL6—chronic obstructive pulmonary disease	6.5e-05	0.000682	CbGpPWpGaD
Glucosamine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.47e-05	0.000679	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	6.35e-05	0.000666	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—KL—chronic obstructive pulmonary disease	6.34e-05	0.000665	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—TLR4—chronic obstructive pulmonary disease	6.27e-05	0.000657	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	6.18e-05	0.000648	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	6.14e-05	0.000644	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	6.13e-05	0.000642	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	6.08e-05	0.000637	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	6.07e-05	0.000636	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—IL6—chronic obstructive pulmonary disease	6.04e-05	0.000633	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	6.02e-05	0.000631	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.99e-05	0.000628	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	5.96e-05	0.000625	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	5.93e-05	0.000621	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.87e-05	0.000616	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.87e-05	0.000616	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	5.86e-05	0.000614	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	5.85e-05	0.000614	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.83e-05	0.000611	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	5.79e-05	0.000607	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	5.78e-05	0.000606	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	5.76e-05	0.000604	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—chronic obstructive pulmonary disease	5.75e-05	0.000603	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	5.69e-05	0.000597	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	5.67e-05	0.000595	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.65e-05	0.000592	CbGpPWpGaD
Glucosamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.65e-05	0.000592	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	5.64e-05	0.000591	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.6e-05	0.000587	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	5.58e-05	0.000585	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	5.53e-05	0.00058	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	5.5e-05	0.000577	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	5.49e-05	0.000576	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL6—chronic obstructive pulmonary disease	5.37e-05	0.000563	CbGpPWpGaD
Glucosamine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.32e-05	0.000558	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	5.3e-05	0.000556	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—TGFB1—chronic obstructive pulmonary disease	5.27e-05	0.000553	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	5.27e-05	0.000553	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—LEP—chronic obstructive pulmonary disease	5.27e-05	0.000552	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	5.23e-05	0.000548	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.21e-05	0.000547	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—TGFB1—chronic obstructive pulmonary disease	5.19e-05	0.000545	CbGpPWpGaD
Glucosamine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.06e-05	0.000531	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	5.04e-05	0.000529	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	5.03e-05	0.000527	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	5e-05	0.000525	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5e-05	0.000525	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	5e-05	0.000525	CbGpPWpGaD
Glucosamine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.99e-05	0.000524	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	4.96e-05	0.00052	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	4.9e-05	0.000514	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.9e-05	0.000514	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—TLR4—chronic obstructive pulmonary disease	4.89e-05	0.000513	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—IL6—chronic obstructive pulmonary disease	4.86e-05	0.000509	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	4.83e-05	0.000507	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	4.76e-05	0.000499	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	4.75e-05	0.000498	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.68e-05	0.00049	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.62e-05	0.000485	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	4.61e-05	0.000483	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.59e-05	0.000481	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	4.58e-05	0.00048	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.52e-05	0.000474	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	4.52e-05	0.000474	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CRP—chronic obstructive pulmonary disease	4.35e-05	0.000456	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	4.3e-05	0.000451	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	4.25e-05	0.000446	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.24e-05	0.000444	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TLR4—chronic obstructive pulmonary disease	4.17e-05	0.000437	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.16e-05	0.000436	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	4.13e-05	0.000433	CbGpPWpGaD
Glucosamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.00043	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	4.08e-05	0.000428	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	3.97e-05	0.000416	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR2—chronic obstructive pulmonary disease	3.93e-05	0.000412	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	3.92e-05	0.000411	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	3.92e-05	0.000411	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.89e-05	0.000408	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.89e-05	0.000408	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.83e-05	0.000402	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	3.83e-05	0.000402	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	3.79e-05	0.000398	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	3.78e-05	0.000397	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—chronic obstructive pulmonary disease	3.7e-05	0.000388	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.69e-05	0.000387	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KL—chronic obstructive pulmonary disease	3.69e-05	0.000387	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	3.63e-05	0.000381	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.61e-05	0.000378	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.57e-05	0.000374	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.53e-05	0.00037	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	3.47e-05	0.000364	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	3.42e-05	0.000359	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.38e-05	0.000355	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	3.32e-05	0.000348	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.24e-05	0.00034	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	3.2e-05	0.000336	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.2e-05	0.000335	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	3.18e-05	0.000334	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR2—chronic obstructive pulmonary disease	3.18e-05	0.000334	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—chronic obstructive pulmonary disease	3.05e-05	0.000319	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.03e-05	0.000317	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	3.01e-05	0.000316	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3e-05	0.000314	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KL—chronic obstructive pulmonary disease	2.99e-05	0.000314	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.98e-05	0.000312	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD8A—chronic obstructive pulmonary disease	2.98e-05	0.000312	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.96e-05	0.00031	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.96e-05	0.00031	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.94e-05	0.000308	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	2.91e-05	0.000306	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.9e-05	0.000304	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	2.83e-05	0.000297	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.82e-05	0.000296	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.82e-05	0.000296	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.000292	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB3—chronic obstructive pulmonary disease	2.77e-05	0.00029	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.76e-05	0.00029	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1B—chronic obstructive pulmonary disease	2.74e-05	0.000287	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.69e-05	0.000282	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.68e-05	0.000281	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	2.61e-05	0.000274	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	2.59e-05	0.000272	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.54e-05	0.000266	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CRP—chronic obstructive pulmonary disease	2.53e-05	0.000265	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.5e-05	0.000262	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.47e-05	0.000259	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.46e-05	0.000258	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR4—chronic obstructive pulmonary disease	2.43e-05	0.000254	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	2.42e-05	0.000254	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD8A—chronic obstructive pulmonary disease	2.41e-05	0.000253	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	2.39e-05	0.00025	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.32e-05	0.000243	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.3e-05	0.000241	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	2.29e-05	0.000241	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	2.27e-05	0.000238	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.27e-05	0.000238	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB3—chronic obstructive pulmonary disease	2.24e-05	0.000235	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.24e-05	0.000235	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.000229	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.16e-05	0.000226	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.15e-05	0.000225	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	2.13e-05	0.000223	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.12e-05	0.000223	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.09e-05	0.000219	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	2.08e-05	0.000219	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.07e-05	0.000217	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CRP—chronic obstructive pulmonary disease	2.05e-05	0.000215	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.01e-05	0.000211	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—chronic obstructive pulmonary disease	1.97e-05	0.000206	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR4—chronic obstructive pulmonary disease	1.97e-05	0.000206	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.92e-05	0.000201	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.88e-05	0.000197	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—chronic obstructive pulmonary disease	1.87e-05	0.000196	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000195	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—LEP—chronic obstructive pulmonary disease	1.81e-05	0.00019	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	1.75e-05	0.000184	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	1.75e-05	0.000183	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.7e-05	0.000178	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.6e-05	0.000167	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.59e-05	0.000166	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—chronic obstructive pulmonary disease	1.58e-05	0.000166	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.58e-05	0.000166	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.58e-05	0.000165	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—chronic obstructive pulmonary disease	1.55e-05	0.000162	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.51e-05	0.000158	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.47e-05	0.000154	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.46e-05	0.000154	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	1.46e-05	0.000154	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.44e-05	0.000151	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.37e-05	0.000143	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.36e-05	0.000143	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.35e-05	0.000142	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—chronic obstructive pulmonary disease	1.28e-05	0.000134	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000131	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.21e-05	0.000127	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000126	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.16e-05	0.000122	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.000121	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.13e-05	0.000118	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.1e-05	0.000116	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.1e-05	0.000115	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.09e-05	0.000114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.06e-05	0.000111	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.05e-05	0.00011	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.83e-06	0.000103	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	9.77e-06	0.000102	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EGFR—chronic obstructive pulmonary disease	9.75e-06	0.000102	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—chronic obstructive pulmonary disease	9.25e-06	9.7e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	8.97e-06	9.4e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EGFR—chronic obstructive pulmonary disease	8.79e-06	9.22e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.37e-06	8.77e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8e-06	8.39e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.91e-06	8.29e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.72e-06	8.09e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—chronic obstructive pulmonary disease	7.49e-06	7.86e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.37e-06	7.73e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.22e-06	7.57e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—chronic obstructive pulmonary disease	6.76e-06	7.09e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.65e-06	6.97e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.54e-06	6.85e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.17e-06	6.47e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	6.1e-06	6.4e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.69e-06	5.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	5.57e-06	5.84e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.54e-06	5.81e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.47e-06	5.73e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.31e-06	5.57e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.13e-06	5.38e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.1e-06	5.34e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.87e-06	5.11e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.83e-06	5.07e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.78e-06	5.01e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.28e-06	4.49e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.22e-06	4.42e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.01e-06	4.21e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.93e-06	4.12e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.73e-06	3.91e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.67e-06	3.85e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	3.28e-06	3.44e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.14e-06	3.29e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.53e-06	2.66e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.42e-06	2.54e-05	CbGpPWpGaD
